银屑病关节炎患者肌肉骨骼超声特征与治疗反应之间的关联
前瞻性队列研究纳入活动性银屑病关节炎患者,基线行64关节、28肌腱和16附着点超声评估,分析超声评分与DAPSA变化及药物持续性的关联。结果显示基线滑膜炎、腱周炎和附着点结构评分较高与随访DAPSA下降更多相关,总炎症评分独立预测DAPSA变化,基线侵蚀评分较高与更早停药相关。
要点
- 基线滑膜炎、腱周炎和附着点结构评分较高与随访DAPSA下降更多相关。
- 总炎症评分独立预测DAPSA变化,不受总结构损伤评分影响。
- 基线超声侵蚀评分较高与更早停药相关(校正HR 1.28,95%CI 1.03至1.61)。
核心结论
- 研究结果提供初步证据支持肌肉骨骼超声用于预测银屑病关节炎的治疗反应和药物持续性。
研究设计与样本
- 前瞻性队列研究,纳入活动性银屑病关节炎患者,共分析135个治疗周期(107例患者)。
- 基线行64个关节、28条肌腱和16个附着点的超声检查,评估滑膜炎、腱周炎、附着点炎、腱鞘炎、新骨形成和侵蚀。
- 计算各病变总评分及总炎症和结构评分,基线临床评估并在开始治疗后3至6个月复评,计算DAPSA评分。
- 采用Cox比例风险模型评估药物持续性,采用广义估计方程模型评估DAPSA变化。
主要发现
- 多变量分析显示,随访时DAPSA评分下降更多与基线滑膜炎评分较高(β -3.89)、腱周炎评分较高(β -3.93)和附着点结构评分较高(β -2.91)相关。
- 总炎症评分独立预测DAPSA变化(β -5.23),不受总结构损伤评分影响。
- 药物持续性分析纳入105个治疗周期,显示基线超声侵蚀评分较高与更早停药相关(校正HR 1.28,95%CI 1.03至1.61)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between musculoskeletal sonographic features and clinical features, as well as treatment outcomes, in patients with active psoriatic arthritis (PsA). METHODS: A prospective cohort study was conducted involving patients with active PsA. Disease activity was assessed clinically at baseline and 3-6 months after initiating therapy, with a Disease Activity Index for PsA (DAPSA) score calculated. A baseline ultrasound examination of 64 joints, 28 tendons and 16 entheses evaluated the following lesions: synovitis, peritenonitis, enthesitis, tenosynovitis, new bone formation and erosions. Total scores for each lesion and total inflammatory and structural scores were calculated. The association between baseline sonographic scores and treatment outcomes was assessed using Cox proportional hazards models (for drug persistence) and generalised estimating equation models for DAPSA change. RESULTS: A total of 135 treatment periods (107 patients) were analysed. Multivariable analysis showed that a greater reduction in DAPSA score at follow-up was associated with higher baseline synovitis (β -3.89), peritenonitis (β -3.93) and enthesitis structural scores (β -2.91). Additionally, the total inflammatory score independently predicted DAPSA change (β -5.23) regardless of the total structural damage score. Drug persistence was analysed in 105 treatment periods, revealing that a higher sonographic erosion score was associated with earlier drug discontinuation (adjusted HR 1.28, 95% CI 1.03 to 1.61). CONCLUSION: The study results provide preliminary evidence supporting the utility of musculoskeletal ultrasound in predicting treatment response and drug persistence in PsA.
引用
- Gutierrez J, Thib S, Koppikar S, et al. Association between musculoskeletal sonographic features and response to treatment in patients with psoriatic arthritis. RMD Open. 2024. PMID: 39477347. doi:10.1136/rmdopen-2023-003995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。